{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:34:06Z","timestamp":1788449646263,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["2020B1111170004"],"award-info":[{"award-number":["2020B1111170004"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["2016005"],"award-info":[{"award-number":["2016005"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313621"],"award-info":[{"award-number":["2018A030313621"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejso.2024.108001","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T12:35:31Z","timestamp":1707395731000},"page":"108001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage"],"prefix":"10.1016","volume":"50","author":[{"given":"Yebing","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-2480","authenticated-orcid":false,"given":"Fujin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.108001_bib1","first-page":"1","article-title":"The multimodal management of locally advanced rectal cancer: making sense of the new data","volume":"42","author":"Zwart","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejso.2024.108001_bib2","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","article-title":"Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Benson","year":"2022","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2024.108001_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2024.108001_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2024.108001_bib6","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.3748\/wjg.v21.i25.7659","article-title":"Rectal cancer: an evidence-based update for primary care providers","volume":"21","author":"Gaertner","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2024.108001_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11912-014-0434-9","article-title":"The neoadjuvant treatment of rectal cancer: a review","volume":"17","author":"Nussbaum","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ejso.2024.108001_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/pin.12409","article-title":"Histological differences between preoperative chemoradiotherapy and chemotherapy for rectal cancer: a clinicopathological study","volume":"66","author":"Sakuyama","year":"2016","journal-title":"Pathol Int"},{"key":"10.1016\/j.ejso.2024.108001_bib9","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/cncr.28331","article-title":"Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy","volume":"119","author":"Agarwal","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2024.108001_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12672-021-00405-w","article-title":"Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer","volume":"12","author":"Caruso","year":"2021","journal-title":"Discov Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JOP.18.00769","article-title":"Nonsurgical management of rectal cancer","volume":"15","author":"Akce","year":"2019","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.ejso.2024.108001_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57101044","article-title":"Evaluation and predictive factors of complete response in rectal cancer after neoadjuvant chemoradiation therapy","volume":"57","author":"Kokaine","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.ejso.2024.108001_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx095","article-title":"Tumor regression grading after preoperative chemoradiotherapy as a prognostic factor and individual-level surrogate for disease-free survival in rectal cancer","volume":"109","author":"Fokas","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2024.108001_bib15","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/annonc\/mdq054","article-title":"Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials","volume":"21","author":"Bujko","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jamaoncol.2017.5597","article-title":"Association between adjuvant chemotherapy and overall survival in patients with rectal cancer and pathological complete response after neoadjuvant chemotherapy and resection","volume":"4","author":"Dossa","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamaoncol.2018.0231","article-title":"Association of adjuvant chemotherapy with overall survival in patients with rectal cancer and pathologic complete response following neoadjuvant chemotherapy and resection","volume":"4","author":"Polanco","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221117875","article-title":"Clinical significance of adjuvant chemotherapy for pathological complete response rectal cancer patients with acellular mucin pools after neoadjuvant chemoradiotherapy","volume":"16","author":"Chen","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.ejso.2024.108001_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000658-200207000-00012","article-title":"Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy","volume":"236","author":"Ruo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.108001_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2014.05.010","article-title":"Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome","volume":"112","author":"Swellengrebel","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10350-005-0133-6","article-title":"Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer","volume":"48","author":"Gavioli","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2024.108001_bib22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2024.108001_bib23","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1200\/JCO.2007.11.9685","volume":"25","author":"Collette","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41416-020-0989-1","article-title":"Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resection","volume":"123","author":"He","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2024.108001_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41419-023-05806-z","article-title":"Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer","volume":"14","author":"K\u00e4llberg","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ejso.2024.108001_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/0008-5472.CAN-14-2240","article-title":"Colorectal cancer heterogeneity and targeted therapy: a case for molecular disease subtypes","volume":"75","author":"Linnekamp","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2024.108001_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00384-014-2082-9","article-title":"A\u00a0systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer","volume":"30","author":"Petrelli","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejso.2024.108001_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.coc.0000214930.78200.4a","article-title":"Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer","volume":"29","author":"Das","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib30","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1200\/JCO.2011.39.7901","article-title":"Neoadjuvant treatment response as an early response indicator for patients with rectal cancer","volume":"30","author":"Park","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108001_bib31","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10350-006-0570-x","article-title":"Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer","volume":"49","author":"Fietkau","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2024.108001_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00535-013-0822-1","article-title":"Histogenesis and prognostic value of myenteric spread in colorectal cancer: a Japanese multi-institutional study","volume":"49","author":"Ueno","year":"2014","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.ejso.2024.108001_bib33","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/ijc.28384","article-title":"Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update","volume":"134","author":"Duffy","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2024.108001_bib34","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.2147\/CMAR.S213580","article-title":"The prognostic value of the postoperative serum CEA levels\/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels","volume":"11","author":"Xie","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2024.108001_bib35","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1002\/cam4.1814","article-title":"The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study","volume":"7","author":"Tong","year":"2018","journal-title":"Cancer Med"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:32:59Z","timestamp":1777573979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0748798324000532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108001","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108001"}}